60
Participants
Start Date
December 17, 2024
Primary Completion Date
May 29, 2026
Study Completion Date
November 30, 2027
TARPEYO®
6-months of TARPEYO® 16 mg QD then 9-month Treatment Period with TARPEYO® 8 mg QD and TARPEYO®4 mg QD for 2 weeks for tapering.
RECRUITING
Chinatown Kidney Care, PLLC, New York
RECRUITING
Icahn School of Medicine at Mount Sinai, New York
RECRUITING
University of Pennsylvania Philadelphia, Philadelphia
RECRUITING
Cobb Nephrology Hypertension Associates, PC, Austell
RECRUITING
Southeastern Clinical Research Institute, LLC, Augusta
RECRUITING
Central Florida Kidney Specialists, Orlando
RECRUITING
Florida Kidney Physicians, Boca Raton
RECRUITING
Univ of Alabama/Birmingham, Birmingham
RECRUITING
Ohio State University, Columbus
RECRUITING
Washington University in St. Louis, St Louis
RECRUITING
Ochsner Health, New Orleans, New Orleans
RECRUITING
Dallas Nephrology Associates McKinney, McKinney
RECRUITING
Dallas Renal Group, Dallas
RECRUITING
Memorial Hermann Houston, Houston
RECRUITING
Prolato Clinical Research Center, Houston
RECRUITING
The Kidney Institute/Houston, Houston
RECRUITING
The University of Texas Medical Branch UTMB, Galveston
RECRUITING
Permian Basin Kidney Center, Odessa
RECRUITING
MedResearch Inc, El Paso
RECRUITING
University of Colorado Hospital (UCH) - Kidney Disease and Hypertension Clinic - Anschutz Medical Campus Location, Aurora
RECRUITING
Arizona Kidney Disease & Hypertension Centers (AKDHC), Glendale
RECRUITING
University of New Mexico, Albuquerque
RECRUITING
Renal Medical Associates, Albuquerque
RECRUITING
UCI Health-UCI Medical Center, Orange
RECRUITING
UCSF Health-UCSF Medical Center-Parnassus - Nephrology and Hypertension Faculty Practice, San Francisco
RECRUITING
Stanford University, Stanford
RECRUITING
Oregon Health & Science University (OHSU) - Nephrology and Hypertension Clinic, Portland
RECRUITING
Yale University Nephrology Clinical Trials Program, New Haven
RECRUITING
Advanced Renal Care Institute, Mayagüez
Lead Sponsor
Collaborators (1)
Worldwide Clinical Trials
OTHER
Calliditas Therapeutics AB
INDUSTRY